|Study Name||Study Title||Status||Recruit.||Contact|
A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinic...
A multicenter, randomized, 52-week, double-blind, parallelgroup,
|CASSIOPEIA (Hovon 131)||
Study of Daratumumab in combination with Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the first Line treatment of transplant eli...
|HOVON 103 AML||
A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition...
|Hovon 132 AML||
Randomized study with a run-in dose-selection phase to assess the added value of
This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.